These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21630509)

  • 21. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
    Chang KJ; Rigdon GC; Howard JL; McNutt RW
    J Pharmacol Exp Ther; 1993 Nov; 267(2):852-7. PubMed ID: 8246159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers.
    Furness MS; Zhang X; Coop A; Jacobson AE; Rothman RB; Dersch CM; Xu H; Porreca F; Rice KC
    J Med Chem; 2000 Aug; 43(16):3193-6. PubMed ID: 10956228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012).
    Fujii H; Takahashi T; Nagase H
    Expert Opin Ther Pat; 2013 Sep; 23(9):1181-208. PubMed ID: 23705966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparameter exploration of piperazine derivatives as δ-opioid receptor agonists for CNS indications.
    McCauley JP; Dantzman CL; King MM; Ernst GE; Wang X; Brush K; Palmer WE; Frietze W; Andisik DW; Hoesch V; Doring K; Hulsizer J; Bui KH; Liu J; Hudzik TJ; Wesolowski SS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1169-73. PubMed ID: 22197139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide.
    Kim IJ; Ullrich T; Janetka JW; Furness MS; Jacobson AE; Rothman RB; Dersch CM; Flippen-Anderson JL; George C; Rice KC
    Bioorg Med Chem; 2003 Nov; 11(22):4761-8. PubMed ID: 14556791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
    Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice.
    O'Neill SJ; Collins MA; Pettit HO; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):271-7. PubMed ID: 9223564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms.
    Tierno A; Fiore P; Gannon RL
    Brain Res; 2002 May; 937(1-2):66-73. PubMed ID: 12020864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
    Su YF; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
    Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH
    Psychopharmacology (Berl); 2002 Oct; 164(1):42-8. PubMed ID: 12373418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
    Negus SS; Butelman ER; Chang KJ; DeCosta B; Winger G; Woods JH
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1025-34. PubMed ID: 7932149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotaxis of human and rat leukocytes by the delta-selective non-peptidic opioid SNC 80.
    Ordaz-Sánchez I; Weber RJ; Rice KC; Zhang X; Rodríguez-Padilla C; Tamez-Guerra R; Méndez-Vázquez JL; Gómez-Flores R
    Rev Latinoam Microbiol; 2003; 45(1-2):16-23. PubMed ID: 17061517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists.
    Bernard D; Coop A; MacKerell AD
    J Am Chem Soc; 2003 Mar; 125(10):3101-7. PubMed ID: 12617677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept.
    Dondio G; Ronzoni S; Eggleston DS; Artico M; Petrillo P; Petrone G; Visentin L; Farina C; Vecchietti V; Clarke GD
    J Med Chem; 1997 Sep; 40(20):3192-8. PubMed ID: 9379438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed cardioprotection is mediated via a non-peptide delta opioid agonist, SNC-121, independent of opioid receptor stimulation.
    Patel HH; Hsu A; Gross GJ
    Basic Res Cardiol; 2004 Jan; 99(1):38-45. PubMed ID: 14685704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.